Florea I - Search Results

1

Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorder.

Baldwin DS, Loft H, Florea I. Baldwin DS, et al. Among authors: florea i. Int Clin Psychopharmacol. 2012 Jul;27(4):197-207. doi: 10.1097/YIC.0b013e3283530ad7. Int Clin Psychopharmacol. 2012. PMID: 22475889 Clinical Trial.

2

Prevention of relapse in generalized anxiety disorder by escitalopram treatment.

Allgulander C, Florea I, Huusom AK. Allgulander C, et al. Among authors: florea i. Int J Neuropsychopharmacol. 2006 Oct;9(5):495-505. doi: 10.1017/S1461145705005973. Epub 2005 Sep 6. Int J Neuropsychopharmacol. 2006. PMID: 16316482 Free article. Clinical Trial.

3

A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder.

Boulenger JP, Loft H, Florea I. Boulenger JP, et al. Among authors: florea i. J Psychopharmacol. 2012 Nov;26(11):1408-16. doi: 10.1177/0269881112441866. Epub 2012 Apr 9. J Psychopharmacol. 2012. PMID: 22495621 Clinical Trial.

4

Vortioxetine (Lu AA21004) in the long-term open-label treatment of major depressive disorder.

Baldwin DS, Hansen T, Florea I. Baldwin DS, et al. Among authors: florea i. Curr Med Res Opin. 2012 Oct;28(10):1717-24. doi: 10.1185/03007995.2012.725035. Epub 2012 Sep 17. Curr Med Res Opin. 2012. PMID: 22978748 Clinical Trial.

5

The effect of vortioxetine on health-related quality of life in patients with major depressive disorder.

Florea I, Danchenko N, Brignone M, Loft H, Rive B, Abetz-Webb L. Florea I, et al. Clin Ther. 2015 Oct 1;37(10):2309-2323.e6. doi: 10.1016/j.clinthera.2015.08.008. Epub 2015 Sep 4. Clin Ther. 2015. PMID: 26346592 Free article. Clinical Trial.

6

The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.

Baldwin DS, Chrones L, Florea I, Nielsen R, Nomikos GG, Palo W, Reines E. Baldwin DS, et al. Among authors: florea i. J Psychopharmacol. 2016 Mar;30(3):242-52. doi: 10.1177/0269881116628440. Epub 2016 Feb 9. J Psychopharmacol. 2016. PMID: 26864543 Free PMC article.

7

A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms.

Baldwin DS, Florea I, Jacobsen PL, Zhong W, Nomikos GG. Baldwin DS, et al. Among authors: florea i. J Affect Disord. 2016 Dec;206:140-150. doi: 10.1016/j.jad.2016.07.015. Epub 2016 Jul 7. J Affect Disord. 2016. PMID: 27474960 Free article.

8

Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder.

McIntyre RS, Florea I, Tonnoir B, Loft H, Lam RW, Christensen MC. McIntyre RS, et al. Among authors: florea i. J Clin Psychiatry. 2017 Jan;78(1):115-121. doi: 10.4088/JCP.16m10744. J Clin Psychiatry. 2017. PMID: 27780334 Free article. Clinical Trial.

9

The effect of vortioxetine on overall patient functioning in patients with major depressive disorder.

Florea I, Loft H, Danchenko N, Rive B, Brignone M, Merikle E, Jacobsen PL, Sheehan DV. Florea I, et al. Brain Behav. 2017 Feb 2;7(3):e00622. doi: 10.1002/brb3.622. eCollection 2017 Mar. Brain Behav. 2017. PMID: 28293465 Free PMC article.

10

Effectiveness of long-term vortioxetine treatment of patients with major depressive disorder.

Vieta E, Loft H, Florea I. Vieta E, et al. Among authors: florea i. Eur Neuropsychopharmacol. 2017 Sep;27(9):877-884. doi: 10.1016/j.euroneuro.2017.06.012. Epub 2017 Jul 8. Eur Neuropsychopharmacol. 2017. PMID: 28693903 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters